These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20102109)

  • 21. 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.
    Hatakeyama T; Kawai N; Nishiyama Y; Yamamoto Y; Sasakawa Y; Ichikawa T; Tamiya T
    Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2009-17. PubMed ID: 18542957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional and metabolic magnetic resonance imaging and positron emission tomography for tumor volume definition in high-grade gliomas.
    Tsien CI; Cao Y; Lawrence TS
    Semin Radiat Oncol; 2009 Jul; 19(3):155-62. PubMed ID: 19464630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of perfusion CT in glioma grading and comparison with conventional MR imaging features.
    Ellika SK; Jain R; Patel SC; Scarpace L; Schultz LR; Rock JP; Mikkelsen T
    AJNR Am J Neuroradiol; 2007; 28(10):1981-7. PubMed ID: 17893216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-modal imaging of tumor cellularity and Tryptophan metabolism in human Gliomas.
    Jeong JW; Juhász C; Mittal S; Bosnyák E; Kamson DO; Barger GR; Robinette NL; Kupsky WJ; Chugani DC
    Cancer Imaging; 2015 Aug; 15(1):10. PubMed ID: 26245742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings.
    Chiang IC; Kuo YT; Lu CY; Yeung KW; Lin WC; Sheu FO; Liu GC
    Neuroradiology; 2004 Aug; 46(8):619-27. PubMed ID: 15243726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioma grading by dynamic susceptibility contrast perfusion and
    Brendle C; Hempel JM; Schittenhelm J; Skardelly M; Reischl G; Bender B; Ernemann U; la Fougère C; Klose U
    Neuroradiology; 2018 Apr; 60(4):381-389. PubMed ID: 29464269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
    Tripathi M; Sharma R; D'Souza M; Jaimini A; Panwar P; Varshney R; Datta A; Kumar N; Garg G; Singh D; Grover RK; Mishra AK; Mondal A
    Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.
    Rossi Espagnet MC; Romano A; Mancuso V; Cicone F; Napolitano A; Scaringi C; Minniti G; Bozzao A
    Br J Radiol; 2016 Oct; 89(1066):20160476. PubMed ID: 27505026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
    Song PJ; Lu QY; Li MY; Li X; Shen F
    J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma.
    Backes H; Ullrich R; Neumaier B; Kracht L; Wienhard K; Jacobs AH
    Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):1960-7. PubMed ID: 19672593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement.
    Widhalm G; Krssak M; Minchev G; Wöhrer A; Traub-Weidinger T; Czech T; Asenbaum S; Marosi C; Knosp E; Hainfellner JA; Prayer D; Wolfsberger S
    J Neurol Neurosurg Psychiatry; 2011 May; 82(5):512-20. PubMed ID: 20971752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging.
    Provenzale JM; McGraw P; Mhatre P; Guo AC; Delong D
    Radiology; 2004 Aug; 232(2):451-60. PubMed ID: 15215555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
    Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
    Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W
    Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy.
    Bradac O; Vrana J; Jiru F; Kramar F; Netuka D; Hrabal P; Horinek D; de Lacy P; Benes V
    Br J Neurosurg; 2014 Oct; 28(5):631-6. PubMed ID: 24377726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas.
    Hara T; Kondo T; Hara T; Kosaka N
    J Neurosurg; 2003 Sep; 99(3):474-9. PubMed ID: 12959432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [(18)F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience.
    Henriksen OM; Larsen VA; Muhic A; Hansen AE; Larsson HBW; Poulsen HS; Law I
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):103-112. PubMed ID: 26363903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of metabolic indices in regions of abnormal perfusion in patients with high-grade glioma.
    Lupo JM; Cha S; Chang SM; Nelson SJ
    AJNR Am J Neuroradiol; 2007 Sep; 28(8):1455-61. PubMed ID: 17846190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.